SCHEMBL20122428

SCHEMBL20122428

CC(=O)OCOC(=O)SC(C)(C)C(=O)N[C@@H](CS)C(=O)OC(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20122386 0.90 — —
SCHEMBL20122432 0.89 KDM4E (0.31) —
SCHEMBL20122400 0.87 — —
SCHEMBL20122429 0.86 CYP1A2 (0.33) —
SCHEMBL20122434 0.86 — —
SCHEMBL20122409 0.86 KDM4E (0.44) —
SCHEMBL20122530 0.86 — —
SCHEMBL20122371 0.82 — —
SCHEMBL20122385 0.80 — —
SCHEMBL20122435 0.80 HDAC4 (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9963428-B1 Bucillamine prodrugs, pharmaceutical compositions thereof, and methods of use Nguyen, Mark Quang (US) 2018-05-08 — — US disclosed
Send feedback